Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$700,141
-$176,617 QoQ
Shares Held
104,188
-8.3% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 133 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. ARCT ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ARCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $700,141 | 104,188 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $876,758 | 113,570 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $632,099 | 103,116 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,188,550 | 64,490 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $583,640 | 44,861 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $369,545 | 34,896 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $323,446 | 19,060 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $437,158 | 18,835 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $454,832 | 18,679 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $673,777 | 19,952 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $417,961 | 13,256 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,412,737 | 133,571 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $304,523 | 10,618 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $236,917 | 9,884 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $429,866 | 25,346 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $390,269 | 26,334 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $411,710 | 26,157 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $586,108 | 21,740 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $305,960 | 8,267 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $458,352 | 9,593 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $296,234 | 8,754 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $234,377 | 5,675 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $360,960 | 8,414 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,325,052 | 220,904 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||